RVMD

Revolution Medicines Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↓ 1/10
  • Value↑ 6/10
Revolution Medicines sales and earnings growth
RVMD Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -66.20%
  • FCF Y/Y↓ -60.94%
Revolution Medicines gross and profit margin trends
RVMD Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -47.88%
Revolution Medicines net debt vs free cash flow
RVMD Risk
Great
  • Debt / Equity↓ 0.3
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -45.7

Revolution Medicines stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗